STING1 and pancreatic ductal adenocarcinoma: Similarly, the increase of proliferative effector CD8+ granzyme B+ T cells in the pancreatic ductal adenocarcinoma (PDAC) TME after treatment with a CD11b agonist was attributed to the induction of a STING-dependent type I IFN signature in TAMs (187).